Grp78 n 20

Manufactured by Santa Cruz Biotechnology

GRP78 (N-20) is a primary antibody product offered by Santa Cruz Biotechnology. It targets the N-terminal region of the GRP78 protein, also known as BiP (Binding Immunoglobulin Protein). GRP78 is a chaperone protein that plays a critical role in the endoplasmic reticulum (ER) stress response.

Automatically generated - may contain errors

Lab products found in correlation

Fibronectin, by Abcam (1 mentions) Collagen type 4, by Merck Group (1 mentions) Flag tag (flag), by Merck Group (1 mentions) Gapdh, by Cell Signaling Technology (1 mentions) P gsk3, by Cell Signaling Technology (1 mentions) Snai1, by Cell Signaling Technology (1 mentions) Cd133, by BioLegend (1 mentions) P akt, by Cell Signaling Technology (1 mentions) Gsk 3, by Merck Group (1 mentions)

2 protocols using grp78 n 20

Antibody Sources for Cellular Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies were purchased from the following sources; fibronectin (catalog# ab2413, Abcam), Collagen type IV (catalog # SAB4500369, Sigma-Aldrich), ATF4 (catalog# sc-200, Santa Cruz Biotechnology), CHOP (catalog# 13172, Novus Biologicals), GAPDH (catalog# 3683; Cell Signaling Technology), GRP78 (N-20, catalog# sc-1050, Santa Cruz Biotechnology), FLAG (catalog# A8592, Sigma), Myocilin (36–135, catalog# H00004653, Abnova).

Kasetti R.B., Patel P.D., Maddineni P, & Zode G.S. (2020). Ex-vivo cultured human corneoscleral segment model to study the effects of glaucoma factors on trabecular meshwork. PLoS ONE, 15(6), e0232111.

+ Open protocol

+ Expand

Antibody Sources for Stem Cell Research

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibody sources were as follows: GRP78 N20 and C20 [Santa Cruz Biotech (Santa Cruz, CA)]; OCT4, SOX9 and GSK3 [Millipore (Temecula, CA)]; CD133 and SCA1 [Biolegend (San Diego, CA)]; SNAI1, p-GSK3, AKT and p-AKT [Cell Signaling Technology (Danvers, MA)]. GRP78 C38 and C107 antibodies were produced in our laboratory (15 (link)).

Mo L., Bachelder R.E., Kennedy M., Chen P.H., Chi J.T., Berchuck A., Cianciolo G, & Pizzo S.V. (2015). Syngeneic murine ovarian cancer model reveals that ascites enriches for ovarian cancer stem-like cells expressing membrane GRP78. Molecular cancer therapeutics, 14(3), 747-756.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!